{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:59:52Z","timestamp":1783490392469,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI15C1142"],"award-info":[{"award-number":["HI15C1142"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study evaluated the clinical activity of RGN-259 (thymosin \u03b24) in comparison with cyclosporine A (CsA), diquafosol (DQS), and lifitegrast (LFA) in a murine model of dry eye. The model was NOD.B10-<jats:italic>H2<\/jats:italic><jats:sup><jats:italic>b<\/jats:italic><\/jats:sup> mice in a 30\u201340% humidified environment together with daily scopolamine hydrobromide injections for 10 days. After desiccation stress, all drugs were evaluated after 10 treatment days. RGN-259 increased tear production similar to that in the DQS- and LFA-treated mice while CsA was inactive. RGN-259 improved corneal smoothness and decreased fluorescein staining similar to that of LFA group while CsA and DQS were inactive. Corneal epithelial detachment was reduced by RGN-259, and DQS and LFA showed similar activity but the CsA was inactive. RGN-259 increased conjunctival goblet cells and mucin production comparable to that seen with CsA, while DQS and LFA were inactive. RGN-259 reduced the over-expression of inflammatory factors comparable to that with CsA and LFA, while DQS was inactive. RGN-259 increased mucin production comparable to that observed with CsA, while DQS and LFA were inactive. In conclusion, RGN-259 promoted recovery of mucins and goblet cells, improved corneal integrity, and reduced inflammation in a dry eye mouse model and was equal to or more effective than prescription treatments.<\/jats:p>","DOI":"10.1038\/s41598-018-28861-5","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T09:30:08Z","timestamp":1530869408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["RGN-259 (thymosin \u03b24) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model"],"prefix":"10.1038","volume":"8","author":[{"given":"Chae Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hynda K.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sosne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W","family":"Ousler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongsoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinwook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewook","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"28861_CR1","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/ICO.0000000000000543","volume":"34","author":"HN Oh","year":"2015","unstructured":"Oh, H. N., Kim, C. E., Lee, J. H. & Yang, J. W. Effects of quercetin in a mouse model of experimental dry eye. Cornea 34, 1130\u20131136 (2015).","journal-title":"Cornea"},{"key":"28861_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"PC Jennifer","year":"2017","unstructured":"Jennifer, P. C. et al. TFOS DEWS II Definition and Classification Report. The Ocular Surface 15, 276\u2013283 (2017).","journal-title":"The Ocular Surface"},{"key":"28861_CR3","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1167\/iovs.09-4562","volume":"51","author":"Z Chen","year":"2010","unstructured":"Chen, Z., Li, Z., Basti, S., Farley, W. J. & Pflugfelder, S. C. Altered morphology and function of the lacrimal functional unit in protein kinase C alpha knockout mice. Invest Ophthalmol Vis Sci 51, 5592\u20135600 (2010).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR4","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1167\/iovs.05-1281","volume":"47","author":"CS De Paiva","year":"2006","unstructured":"De Paiva, C. S. et al. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci 47, 2847\u20132856 (2006).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","volume":"126","author":"S Rashid","year":"2008","unstructured":"Rashid, S. et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 126, 219\u2013225 (2008).","journal-title":"Arch Ophthalmol"},{"key":"28861_CR6","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp, M. A. Report of the national eye institute\/industry workshop on clinical trials in dry eyes. Clao J 21, 221\u2013332 (1995).","journal-title":"Clao J"},{"key":"28861_CR7","first-page":"1210","volume":"21","author":"CE Kim","year":"2015","unstructured":"Kim, C. E., Oh, H. N., Lee, J. H. & Yang, J. W. Effects of chondrocyte-derived extracellular matrix in a dry eye mouse model. Mol Vis 21, 1210\u20131223 (2015).","journal-title":"Mol Vis"},{"key":"28861_CR8","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1167\/iovs.08-1734","volume":"49","author":"P Situ","year":"2008","unstructured":"Situ, P., Simpson, T. L., Fonn, D. & Jones, L. W. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness. Invest Ophthalmol Vis Sci 49, 2971\u20132976 (2008).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR9","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/S0039-6257(00)00203-4","volume":"45","author":"M Rolando","year":"2001","unstructured":"Rolando, M. & Zierhut, M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 45, S203\u2013S210 (2001).","journal-title":"Surv Ophthalmol"},{"key":"28861_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/09273941003721926","volume":"18","author":"M Calonge","year":"2010","unstructured":"Calonge, M. et al. Dry eye disease as an inflammatory disorder. Ocul Immunol Inflamm 18, 244\u2013253 (2010).","journal-title":"Ocul Immunol Inflamm"},{"key":"28861_CR11","first-page":"862","volume":"16","author":"A Enr\u00edquez-de-Salamanca","year":"2010","unstructured":"Enr\u00edquez-de-Salamanca, A. et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis 16, 862\u2013873 (2010).","journal-title":"Mol Vis"},{"key":"28861_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/CIA.S40640","volume":"8","author":"MD Pinazo-Dur\u00e1n","year":"2013","unstructured":"Pinazo-Dur\u00e1n, M. D. et al. Effects of a nutraceutical formulation based on the combination of antioxidants and \u03c9-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin Interv Aging 8, 139\u2013148 (2013).","journal-title":"Clin Interv Aging"},{"key":"28861_CR13","first-page":"711","volume":"8","author":"C Galbis-Estrada","year":"2013","unstructured":"Galbis-Estrada, C. et al. Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. Clin Interv Aging 8, 711\u2013719 (2013).","journal-title":"Clin Interv Aging"},{"key":"28861_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep44364","volume":"7","author":"CE Kim","year":"2017","unstructured":"Kim, C. E., Lee, J. H., Yeon, Y. K., Park, C. H. & Yang, J. Effects of silk fibroin in murine dry eye. Sci Rep 7, 44364 (2017).","journal-title":"Sci Rep"},{"key":"28861_CR15","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1167\/iovs.16-20843","volume":"58","author":"H Lee","year":"2017","unstructured":"Lee, H. et al. Therapeutic efficacy of nanocomplex of poly(Ethylene Glycol) and catechin for dry eye disease in a mouse model. Invest Ophthalmol Vis Sci 58, 1682\u20131691 (2017).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07965-4","volume":"7","author":"H Lee","year":"2017","unstructured":"Lee, H., Kim, C. E., Ahn, B. N. & Yang, J. Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse. Sci Rep 7, 7413 (2017).","journal-title":"Sci Rep"},{"key":"28861_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-4615-5359-5_32","volume":"438","author":"IK Gipson","year":"1998","unstructured":"Gipson, I. K. & Inatomi, T. Cellular origin of mucins of the ocular surface tear film. Adv Exp Med Biol 438, 221\u2013227 (1998).","journal-title":"Adv Exp Med Biol"},{"key":"28861_CR18","first-page":"2602","volume":"39","author":"Y Danjo","year":"1998","unstructured":"Danjo, Y. et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci 39, 2602\u20132609 (1998).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR19","first-page":"1004","volume":"43","author":"P Argueso","year":"2002","unstructured":"Argueso, P. et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci 43, 1004\u20131011 (2002).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1542-0124(12)70149-0","volume":"2","author":"IK Gipson","year":"2004","unstructured":"Gipson, I. K., Hori, Y. & Argueso, P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf 2, 131\u2013148 (2004).","journal-title":"Ocul Surf"},{"key":"28861_CR21","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1167\/iovs.11-7655","volume":"52","author":"RM Corrales","year":"2011","unstructured":"Corrales, R. M. et al. Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Invest Ophthalmol Vis Sci 52, 8363\u20138369 (2011).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.aanat.2007.05.001","volume":"190","author":"F Paulsen","year":"2008","unstructured":"Paulsen, F. et al. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann Anat 190, 59\u201370 (2008).","journal-title":"Ann Anat"},{"key":"28861_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/ACI.0000000000000098","volume":"14","author":"DA Dartt","year":"2014","unstructured":"Dartt, D. A. & Masli, S. Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation. Curr Opin Allergy Clin Immunol 14, 464\u2013470 (2014).","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"28861_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.exer.2007.11.013","volume":"86","author":"DF Yu","year":"2008","unstructured":"Yu, D. F. et al. MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sj\u00f6gren syndrome patients. Exp Eye Res 86, 403\u2013411 (2008).","journal-title":"Exp Eye Res"},{"key":"28861_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ACI.0b013e32830e6b04","volume":"8","author":"F Mantelli","year":"2008","unstructured":"Mantelli, F. & Argueso, P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol 8, 477\u2013483 (2008).","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"28861_CR26","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1167\/iovs.02-1319","volume":"44","author":"XJ Song","year":"2003","unstructured":"Song, X. J. et al. Neurturindeficient mice develop dry eye and keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 44, 4223\u20134239 (2003).","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"28861_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0137-5","volume":"15","author":"K Shirai","year":"2015","unstructured":"Shirai, K. & Saika, S. Ocular surface mucins and local inflammation\u2013studies in genetically modified mouse lines. BMC Ophthalmol 15(Suppl 1), 154 (2015).","journal-title":"BMC Ophthalmol"},{"key":"28861_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2006.04.020","volume":"131","author":"M Van der Sluis","year":"2006","unstructured":"Van der Sluis, M. et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117\u2013129 (2006).","journal-title":"Gastroenterology"},{"key":"28861_CR29","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1167\/iovs.13-12955","volume":"55","author":"K Shirai","year":"2014","unstructured":"Shirai, K. et al. Effects of the loss of conjunctival Muc16 on corneal epithelium and stroma in mice. Invest Ophthalmol Vis Sci 55, 3626\u20133637 (2014).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1749-6632.2010.05492.x","volume":"1194","author":"D Crockford","year":"2010","unstructured":"Crockford, D., Turjman, N., Allan, C. & Angel, J. Thymosinbeta4: structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci 1194, 179\u2013189 (2010).","journal-title":"Ann N Y Acad Sci"},{"key":"28861_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1517\/14712598.2012.634793","volume":"12","author":"AL Goldstein","year":"2012","unstructured":"Goldstein, A. L., Hannappel, E., Sosne, G. & Kleinman, H. K. Thymosin beta 4: a multifunctional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther 12, 37\u201351 (2012).","journal-title":"Expert Opin Biol Ther"},{"key":"28861_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1357-2725(00)00087-X","volume":"33","author":"T Huff","year":"2001","unstructured":"Huff, T., M\u00fcller, C. S., Otto, A. M., Netzker, R. & Hannappel, E. Beta-thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33, 205\u2013220 (2001).","journal-title":"Int J Biochem Cell Biol"},{"key":"28861_CR33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0021-9258(19)68299-2","volume":"257","author":"TL Low","year":"1982","unstructured":"Low, T. L. & Goldstein, A. L. Chemical characterization of thymosin beta 4. J Biol Chem 257, 1000\u20131006 (1982).","journal-title":"J Biol Chem"},{"key":"28861_CR34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature03000","volume":"432","author":"I Bock-Marquette","year":"2004","unstructured":"Bock-Marquette, I., Saxena, A., White, M. D., Dimaio, J. M. & Srivastava, D. Thymosin \u03b24 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466\u2013472 (2004).","journal-title":"Nature"},{"key":"28861_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1523-1747.1999.00708.x","volume":"113","author":"KM Malinda","year":"1999","unstructured":"Malinda, K. M. et al. Thymosin \u03b24 accelerates wound healing. J Invest Dermatol 113, 364\u2013368 (1999).","journal-title":"J Invest Dermatol"},{"key":"28861_CR36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1167\/iovs.03-1002","volume":"45","author":"G Sosne","year":"2004","unstructured":"Sosne, G., Siddiqi, A. & Kurpakus-Wheater, M. Thymosin-\u03b24 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest Ophthalmol Vis Sci 45, 1095\u20131100 (2004).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.neuroscience.2010.05.017","volume":"169","author":"D Morris","year":"2010","unstructured":"Morris, D., Chopp, M., Zhang, L., Lu, M. & Zhang, Z. G. T\u03b24 Improves functional neurological outcome in a rat model of embolic stroke. Neuroscience 169, 674\u2013682 (2010).","journal-title":"Neuroscience"},{"key":"28861_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1076\/ceyr.24.4.268.8414","volume":"24","author":"G Sosne","year":"2002","unstructured":"Sosne, G., Hafeez, S., Greenberry, A. L. 2nd & Kurpakus-Wheater, M. Thymosin beta 4 promotes human conjunctival epithelial cell migration. Curr Eye Res 24, 268\u2013273 (2002).","journal-title":"Curr Eye Res"},{"key":"28861_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/exer.2001.1125","volume":"74","author":"G Sosne","year":"2002","unstructured":"Sosne, G. et al. Thymosin \u03b24 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 74, 293\u2013299 (2002).","journal-title":"Exp Eye Res"},{"key":"28861_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yexcr.2003.09.022","volume":"293","author":"G Sosne","year":"2004","unstructured":"Sosne, G. et al. Thymosin \u03b24 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res 293, 175\u2013183 (2004).","journal-title":"Exp Cell Res"},{"key":"28861_CR41","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.neuroscience.2009.09.054","volume":"164","author":"J Zhang","year":"2009","unstructured":"Zhang, J. et al. Neurological function recovery after T\u03b24 treatment in mice with experimental auto encephalomyelitis. Neuroscience 164, 1887\u20131893 (2009).","journal-title":"Neuroscience"},{"key":"28861_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.exer.2006.12.004","volume":"84","author":"G Sosne","year":"2007","unstructured":"Sosne, G., Qiu, P., Christopherson, P. L. & Wheater, M. K. Thymosin \u03b24 suppression of corneal NF\u03baB. A potential anti-inflammatory pathway. Exp Eye Res 84, 663\u2013669 (2007).","journal-title":"Exp Eye Res"},{"key":"28861_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1749-6632.2010.05471.x","volume":"1194","author":"SP Dunn","year":"2010","unstructured":"Dunn, S. P. et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin \u03b24. Ann NY Acad Sci 1194, 199\u2013206 (2010).","journal-title":"Ann NY Acad Sci"},{"key":"28861_CR44","first-page":"877","volume":"9","author":"G Sosne","year":"2015","unstructured":"Sosne, G. & Ousler, G. W. Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE\u2122) model. Clin Ophthalmol 9, 877\u2013884 (2015).","journal-title":"Clin Ophthalmol"},{"key":"28861_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/ICO.0000000000000379","volume":"34","author":"G Sosne","year":"2015","unstructured":"Sosne, G., Dunn, S. P. & Kim, C. Thymosin \u03b24 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea 34, 491\u20136 (2015).","journal-title":"Cornea"},{"key":"28861_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall, K., Stevenson, O. D., Mundorf, T. K. & Reis, B. L. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107, 631\u2013639 (2000).","journal-title":"Ophthalmology"},{"key":"28861_CR47","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","volume":"118","author":"KS Kunert","year":"2000","unstructured":"Kunert, K. S., Tisdale, A. S., Stern, M. E., Smith, J. A. & Gipson, I. K. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 118, 1489\u20131496 (2000).","journal-title":"Arch Ophthalmol"},{"key":"28861_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/OPTO.S68271","volume":"7","author":"WH Ridder","year":"2015","unstructured":"Ridder, W. H. & Karsolia, A. New drugs for the treatment of dry eye disease. Clin Optometry 7, 91\u2013102 (2015).","journal-title":"Clin Optometry"},{"key":"28861_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/jop.2016.0105","volume":"33","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder, S. C., Stern, M., Zhang, S. & Shojaei, A. LFA-1\/ICAM-1 interaction as a therapeutic target in dry eye disease. J Ocul Pharmacol Ther 33, 5\u201312 (2017).","journal-title":"J Ocul Pharmacol Ther"},{"key":"28861_CR50","doi-asserted-by":"crossref","unstructured":"Dube, K.N. et al. Recapitulation of developmental mechanisms to revascularize the ischemic heart. JCI Insight 2, in press (2018).","DOI":"10.1172\/jci.insight.96800"},{"key":"28861_CR51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/jnc.13394","volume":"136","author":"M Santra","year":"2016","unstructured":"Santra, M. et al. Thymosin beta 4 upregulates Mir-200a expression and induces differentiation and survival of rat brain progenitor cells. J Neurochem 136, 118\u2013132 (2016).","journal-title":"J Neurochem"},{"key":"28861_CR52","first-page":"751","volume":"102","author":"HK Kleinman","year":"2016","unstructured":"Kleinman, H. K. & Sosne, G. Thymosin beta4 promotes dermal healing. Vitamin Horm 102, 751\u2013775 (2016).","journal-title":"Vitamin Horm"},{"key":"28861_CR53","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1167\/iovs.07-0069","volume":"48","author":"CS De Paiva","year":"2007","unstructured":"De Paiva, C. S. et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci 48, 2553\u20132560 (2007).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/mi.2009.5","volume":"2","author":"CS De Paiva","year":"2009","unstructured":"De Paiva, C. S. et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2, 243\u2013253 (2009).","journal-title":"Mucosal Immunol"},{"key":"28861_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/rheumatology\/kep357","volume":"49","author":"CS De Paiva","year":"2010","unstructured":"De Paiva, C. S. et al. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren\u2019s syndrome-like kerato-conjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) 49, 246\u2013258 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"28861_CR56","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","volume":"147","author":"H Lam","year":"2009","unstructured":"Lam, H. et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 147, 198\u2013205 (2009).","journal-title":"Am J Ophthalmol"},{"key":"28861_CR57","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","volume":"176","author":"JY Niederkorn","year":"2006","unstructured":"Niederkorn, J. Y. et al. Desiccating stress induces T cell-mediated Sjogren\u2019s Syndrome-like lacrimal keratoconjunctivitis. J Immunol 176, 3950\u20133957 (2006).","journal-title":"J Immunol"},{"key":"28861_CR58","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1006\/exer.2001.1054","volume":"73","author":"DQ Li","year":"2001","unstructured":"Li, D. Q. et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 73, 449\u2013459 (2001).","journal-title":"Exp Eye Res"},{"key":"28861_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","volume":"166","author":"SC Pflugfelder","year":"2005","unstructured":"Pflugfelder, S. C. et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 166, 61\u201371 (2005).","journal-title":"Am J Pathol"},{"key":"28861_CR60","first-page":"2283","volume":"42","author":"A Solomon","year":"2001","unstructured":"Solomon, A. et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 42, 2283\u20132292 (2001).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28861_CR61","first-page":"2400","volume":"17","author":"A Higuchi","year":"2011","unstructured":"Higuchi, A., Kawakita, T. & Tsubota, K. IL-6 induction in desiccated corneal epithelium in vitro and in vivo. Mol Vis 17, 2400\u20132406 (2011).","journal-title":"Mol Vis"},{"key":"28861_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"KC Yoon","year":"2007","unstructured":"Yoon, K. C., Jeong, I. Y., Park, Y. G. & Yang, S. Y. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26, 431\u2013437 (2007).","journal-title":"Cornea"},{"key":"28861_CR63","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.exer.2010.02.014","volume":"90","author":"B Govindarajan","year":"2010","unstructured":"Govindarajan, B. & Gipson, I. K. Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res 90, 655\u2013663 (2010).","journal-title":"Exp Eye Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28861-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:27:52Z","timestamp":1671607672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28861-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28861-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]},"assertion":[{"value":"29 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.S. is a consultant for GtreeBNT Co., Ltd. K.K. and S.K. are employees of RegenTree and GtreeBNT Co. Ltd., a parent company of RegenTree, and have stock options in GtreeBNT. H.K.K. is an employee of RegenTree and has stock in GtreeBNT. The other authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10500"}}